“…Recent developments in the pharmaceutical industry highlighted challenges regarding sustainable packaging of drugs derived from new molecular entities and delicate active pharmaceutical ingredients. , A commentary published during the first few months of the COVID-19 pandemic underscored the enormous need for billions of vials to contain coronavirus vaccine doses and praised the appropriateness of glass, the primary packaging of choice, particularly due to its superior long-term storage and low gas permeability . Nonetheless, silicate glass is chemically reactive vis à vis aqueous phases despite its apparent chemical inertness. , This extremely slow but inexorable glass surface dissolution can adopt different mechanisms of ion exchange and surface hydration, which leads from alkali-depleted layers, up to hydrolysis of the silicon–oxygen bonds, subsequently inducing thickness loss by network dissolution, especially in basic media. − These mechanisms depend not only on the glass composition and network structure but also on the solution in contact with the glass surface. Reactive excipient solutions in which molecular entities are conditioned can still interact aggressively with the glass container, altering the glass surface, and ultimately producing a silica-rich gel layer likely to detach from the surface, or precipitate particles from the ions in solution and constituents of the drug product, pitting, or glass flakes (lamellae) through delamination, as exemplified by the photograph of Figure A.…”